Vivian Blunk

机构：Pfizer (United States)

发表论文 9 篇 · 总被引 42 次 · h-index 4

代表论文

• Epidemiology, Treatment Trends, and Outcomes of Multiple Myeloma in the Middle East and Africa: A Systematic Review (2024 · Clinical Hematology International · 被引 15)
• A systematic review on the epidemiology and treatment options of multiple Myeloma in Asia (2024 · Heliyon · 被引 9)
• Multiple myeloma in Latin America: A systematic review (2024 · eJHaem · 被引 8)
• EFFICACY AND SAFETY OF ELRANATAMAB IN PATIENTS WITH RELAPSED OR REFRACTORY MULTIPLE MYELOMA AND PRIOR B-CELL MATURATION ANTIGEN–DIRECTED THERAPIES: A POOLED ANALYSIS FROM MAGNETISMM STUDIES (2023 · Hematology Transfusion and Cell Therapy · 被引 4)
• Real-World Study in Acute Leukemia: Epidemiology, Treatment Patterns and Outcomes for Newly Diagnosed AML in Adult Patients from Latin America - Loyal Study (2023 · Blood · 被引 3)
• EFFICACY AND SAFETY OF ELRANATAMAB BY AGE AND FRAILTY IN PATIENTS WITH RELAPSED/REFRACTORY MULTIPLE MYELOMA: A SUBGROUP ANALYSIS FROM MAGNETISMM-3 (2023 · Hematology Transfusion and Cell Therapy · 被引 1)